Ardsley Advisory Partners grew its holdings in CymaBay Therapeutics Inc. by 66.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 50,210 shares of the biopharmaceutical company's stock after purchasing an additional 20,000 shares during the quarter.
http://ift.tt/2zynEuw
No comments:
Post a Comment